Navigation Links
Novartis awards 2010 Prizes for Immunology in recognition of outstanding contributions to immunology in medical research
Date:8/23/2010

This press release is available in French and German.

Basel, August 23, 2010 Today, the Novartis 2010 Immunology Prizes were presented at the 16th International Congress of Immunology in Kobe, Japan. Since 1992, the Novartis Prizes for Immunology have been awarded every third year for outstanding contributions to basic and clinical immunology. The prizes recognize individual achievement and provide financial support for further research by the recipients. The prizes are a major feature of the triennial International Congress of Immunology.

Professor Michael Bevan, Howard Hughes Medical Institute, University of Washington, Seattle, US, was awarded the Basic Immunology Prize for his research on T-cell selection and regulation and memory formation of CD8+ cytotoxic T cells in response to pathogens. His observations have led to a better understanding of how effective memory responses of T-cells - key players in the immune response - are generated. Several strategies underlying immunotherapy and cancer vaccine development are based on Professor Bevan's research.

Professor Charles Dinarello, University of Colorado at Denver, US, and Professor Juerg Tschopp, University of Lausanne, Switzerland, shared the Clinical Immunology Prize for their contributions to the discovery and regulation of Interleukin-1 beta and its biological properties as well as the use of IL-1 beta antagonists for the successful treatment of certain inflammatory diseases such as periodic inflammatory syndromes and gout.

"We are pleased to honor these scientists for their outstanding achievements which have not only lead to a better understanding of the immune system, but also to the development of therapies for immunological diseases," said Professor Dhavalkumar Patel, Head of NIBR Europe and Global Head of the Autoimmunity, Transplantation and Inflammation Disease Area at the Novartis Institutes for BioMedical Research (NIBR). "The Novartis Immunology Prizes are an integral part of our commitment to and appreciation of scientific innovation."

The winners of this year's prizes were selected by an independent panel of immunology experts chaired by Sir Andrew McMichael of the Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. The Novartis Prizes are each worth CHF 100 000, and may be shared between more than one individual.


'/>"/>

Contact: Jeffrey Lockwood
jeffrey.lockwood@novartis.com
617-871-7026
Novartis Institutes for BioMedical Research
Source:Eurekalert

Related biology news :

1. Iowa State awards grants to develop health, energy and research technologies
2. NSF awards $10M to develop computing techniques for measuring and analyzing child behavior
3. NOAA awards grant to investigate impacts of land use and climate change on hypoxia in Green Bay
4. NOAA awards $2.5 million for research on invasive species in the Great Lakes
5. Max Planck Innovation awards license for actin marker LifeAct
6. NIH awards National Jewish Health $31 million to lead study of infections associated with eczema
7. NIH awards Rice $1.7M for cartilage-regeneration research
8. International AIDS Society announces inaugural recipients of innovative HIV research awards
9. The Samuel Waxman Cancer Research Foundation awards $1.54 million in research grants for 2010-2011
10. Touch Bionics announced as a winner in the Seventh Annual International Business Awards
11. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... --  iSpecimen ®, the marketplace for human ... (DPS), a full-service anatomic pathology reference lab serving ... , has joined a program offered by iSpecimen ... to make human biospecimens and associated data available to ... in 2015 as a collaboration between iSpecimen and DHIN, ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com ... ... cancer conditions are being pressured as of late due to ... cancer pain management has a dramatic impact on patient,s quality ... and development activities for identifying new forms of opioid formulations ...
(Date:3/22/2017)... March 22, 2017   Boston Biomedical , an ... designed to target cancer stemness pathways, today announced its ... as Chief Executive Officer, effective April 24, 2017. ... J. Li , M.D., FACP, who has led Boston ... Under his leadership, Boston Biomedical has grown from a ...
(Date:3/22/2017)... (PRWEB) , ... March 21, 2017 , ... Premier executive ... & Life Science Search Firm by Hunt Scanlon Media. , Hunt Scanlon ... and the most widely referenced global news source in the human capital sector. , ...
Breaking Biology Technology: